Guangzhou Pengjiao Biotechnology Pharmaceutical Co., Ltd. is an innovative pharmaceutical company focused on the treatment of obesity and weight management. The company is dedicated to providing safe and effective solutions for the global overweight and obese population through cutting-edge technology and precision medicine. It possesses an international R&D team, a GMP-compliant production base, and a global sales network covering major markets. Guided by the mission of ‌"Scientific Weight Loss, Reshaping Healthy Life"‌, the company drives innovation and breakthroughs in the field of obesity treatment.

Since its establishment, Purui Bioscience has focused on researching the pathological mechanisms of obesity, combining directions such as metabolic regulation, gut microbiota intervention, and neuroendocrine regulation. It has developed multiple innovative drugs and health management solutions with independent intellectual property rights and has become a leading domestic platform for the R&D and industrialization of weight-loss drugs.

Social Responsibility and Vision‌

Guangzhou Pengjiao Biotechnology Pharmaceutical Co., Ltd. actively fulfills its corporate social responsibility:

Establishes an ‌"Obesity Prevention and Control Public Welfare Fund"‌ to support grassroots obesity screening and health education.

Promotes a ‌"Healthy Weight Campus Plan"‌ to assist in the prevention of obesity among adolescents.

Strictly adheres to ethical norms to ensure the transparency and compliance of clinical trials.

Looking ahead, the company will continue to drive forward with a "technology + humanities" dual-wheel approach, breaking through technical bottlenecks in obesity treatment, developing safer and more convenient innovative products, and helping the global obese population regain health and confidence. It aims to become a trusted leader in the weight management field.

‌Corporate Vision:‌Let scientific weight loss benefit everyone.